{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:07:25Z","timestamp":1794377245379,"version":"4.9.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1S10 OD032209-01"],"award-info":[{"award-number":["1S10 OD032209-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103430"],"award-info":[{"award-number":["P20GM103430"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21 AA029750"],"award-info":[{"award-number":["R21 AA029750"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000146","name":"National Science Foundation Division of Chemical Bioengineering Environmental and Transport Systems","doi-asserted-by":"publisher","award":["1919588"],"award-info":[{"award-number":["1919588"]}],"id":[{"id":"10.13039\/100000146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005714","name":"Established Program to Stimulate Competitive Research","doi-asserted-by":"publisher","award":["-1655221"],"award-info":[{"award-number":["-1655221"]}],"id":[{"id":"10.13039\/100005714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biomaterials.2025.123623","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T14:48:49Z","timestamp":1754750929000},"page":"123623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A novel Kupffer cell-targeting nanoparticle system to Mitigate alcohol-associated liver disease"],"prefix":"10.1016","volume":"325","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7841-3564","authenticated-orcid":false,"given":"Janitha M.","family":"Unagolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalindu","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youbin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6364-3480","authenticated-orcid":false,"given":"Curtis","family":"Soloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Slitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0762-3513","authenticated-orcid":false,"given":"Jyothi U.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2025.123623_bib1","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.3748\/wjg.v28.i36.5280","article-title":"Liver-specific drug delivery platforms: applications for the treatment of alcohol-associated liver disease","volume":"28","author":"Warner","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1524-6175.2004.04463.x","article-title":"Excessive alcohol consumption and hypertension: clinical implications of current research","volume":"7","author":"Miller","year":"2005","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.biomaterials.2025.123623_bib3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/add.14703","article-title":"Alcohol use disorders and the heart","volume":"114","author":"Day","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.biomaterials.2025.123623_bib4","first-page":"1","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.biomaterials.2025.123623_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib7","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1016\/S2468-2667(20)30062-1","article-title":"Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019\u201340: a modelling study","volume":"5","author":"Julien","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.biomaterials.2025.123623_bib8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cgh.2017.11.045","article-title":"Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib9","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2025.123623_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","author":"Thursz","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib11","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"Czaja","year":"2014","journal-title":"World J. Gastroenterol. WJG"},{"key":"10.1016\/j.biomaterials.2025.123623_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00218","article-title":"Targeting of hepatic macrophages by therapeutic nanoparticles","volume":"11","author":"Colino","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib14","first-page":"785","article-title":"Kupffer cells in the liver, compr","volume":"3","author":"Dixon","year":"2013","journal-title":"Physiologist"},{"key":"10.1016\/j.biomaterials.2025.123623_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib16","doi-asserted-by":"crossref","DOI":"10.1039\/D5PM00044K","article-title":"Biomimetic nanoparticles for targeted therapy of liver disease","author":"Vijayan","year":"2025","journal-title":"RSC Pharm"},{"key":"10.1016\/j.biomaterials.2025.123623_bib17","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein coupled bile acid receptor Gpbar1 (TGR5) negatively regulates hepatic inflammatory response through antagonizing Nuclear Factor \u03baB","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.biomaterials.2025.123623_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0038-1669940","article-title":"Role of TGR5 (GPBAR1) in liver disease","volume":"38","author":"Keitel","year":"2018","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.biomaterials.2025.123623_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijbiomac.2018.12.178","article-title":"Efficient fabrication of reversible pH-induced carboxymethyl chitosan nanoparticles for antitumor drug delivery under weakly acidic microenvironment","volume":"126","author":"Li","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13320-4","article-title":"Dual-drug containing core-shell nanoparticles for lung cancer therapy","volume":"7","author":"Menon","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2025.123623_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.colsurfb.2017.02.025","article-title":"The pH sensitive properties of carboxymethyl chitosan nanoparticles cross-linked with calcium ions","volume":"153","author":"Kalliola","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biomaterials.2025.123623_bib23","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1039\/D4TB01682C","article-title":"Citrus pectin-coated inhalable PLGA nanoparticles for treatment of pulmonary fibrosis","volume":"13","author":"Perera","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biomaterials.2025.123623_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213430","article-title":"Development and characterization of lung surfactant-coated polymer nanoparticles for pulmonary drug delivery","volume":"150","author":"Gonsalves","year":"2023","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.biomaterials.2025.123623_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109393","article-title":"Modeling alcohol-associated liver disease in a human Liver-Chip","volume":"36","author":"Nawroth","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.biomaterials.2025.123623_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biomaterials.2025.123623_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1205821","article-title":"Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles","volume":"14","author":"Aghara","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biomaterials.2025.123623_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124381","article-title":"Targeting chronic liver diseases: molecular markers, drug delivery strategies and future perspectives","volume":"660","author":"Unagolla","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123623_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2012.05.010","article-title":"Targeting tumor antigens to dendritic cells using particulate carriers","volume":"161","author":"Joshi","year":"2012","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.biomaterials.2025.123623_bib31","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ajpath.2020.08.014","article-title":"Kupffer cells: inflammation pathways and cell-cell interactions in alcohol-associated liver disease","volume":"190","author":"Slevin","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib32","first-page":"455","article-title":"Effect of Kupffer cells depletion on ABC phenomenon induced by Kupffer cells-targeted liposomes","volume":"14","author":"Lai","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.biomaterials.2025.123623_bib33","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1039\/D1TB01934A","article-title":"Synthesis and characterization of a novel pH-responsive drug-releasing nanocomposite hydrogel for skin cancer therapy and wound healing","volume":"9","author":"Gonsalves","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biomaterials.2025.123623_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.11.028","article-title":"Encapsulation of dexamethasone into biodegradable polymeric nanoparticles","volume":"331","author":"G\u00f3mez-Gaete","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123623_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2006.11.028","article-title":"Encapsulation of dexamethasone into biodegradable polymeric nanoparticles","volume":"331","author":"Gomezgaete","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123623_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/jfb7030021","article-title":"pH-responsive PLGA nanoparticle for controlled payload delivery of diclofenac sodium","volume":"7","author":"Khanal","year":"2016","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.biomaterials.2025.123623_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.35946\/arcr.v38.2.02","article-title":"Alcohol and gut-derived inflammation","volume":"38","author":"Bishehsari","year":"2017","journal-title":"Alcohol Res"},{"key":"10.1016\/j.biomaterials.2025.123623_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/toxics5030015","article-title":"Revelation of different nanoparticle-uptake behavior in two standard cell lines NIH\/3T3 and A549 by flow cytometry and time-lapse imaging","volume":"5","author":"Jochums","year":"2017","journal-title":"Toxics"},{"key":"10.1016\/j.biomaterials.2025.123623_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.molimm.2017.02.018","article-title":"The role of Kupffer cells in hepatic diseases","volume":"85","author":"Li","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1039\/c0fo00113a","article-title":"Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages: a tool to study inflammation modulating effects of food-derived compounds","volume":"1","author":"Chanput","year":"2010","journal-title":"Food Funct."},{"key":"10.1016\/j.biomaterials.2025.123623_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4049\/jimmunol.170.1.158","article-title":"Critical paracrine interactions between TNF-\u03b1 and IL-10 regulate lipopolysaccharide-stimulated human choriodecidual cytokine and prostaglandin E2 Production1","volume":"170","author":"Sato","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbadis.2018.11.008","article-title":"Effect of alcohol on the interleukin 6-mediated inflammatory response in a new mouse model of acute-on-chronic liver injury","volume":"1865","author":"Karatayli","year":"2019","journal-title":"Biochim. Biophys. Acta BBA - Mol. Basis Dis."},{"key":"10.1016\/j.biomaterials.2025.123623_bib43","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bbadis.2010.07.023","article-title":"Role of IL-6 trans-signaling in CCl4 induced liver damage","volume":"1802","author":"Gewiese-Rabsch","year":"2010","journal-title":"Biochim. Biophys. Acta BBA - Mol. Basis Dis."},{"key":"10.1016\/j.biomaterials.2025.123623_bib44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40164-024-00527-1","article-title":"The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases","volume":"13","author":"Wang","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/diseases12040069","article-title":"The role of cytokines in the pathogenesis and treatment of alcoholic liver disease","volume":"12","author":"Scarlata","year":"2024","journal-title":"Diseases"},{"key":"10.1016\/j.biomaterials.2025.123623_bib46","first-page":"249","article-title":"[Serum cytokine concentration as prognostic factor in patients with alcoholic liver disease]","volume":"63","author":"Cie\u0107ko-Michalska","year":"2006","journal-title":"Przegl. Lek."},{"key":"10.1016\/j.biomaterials.2025.123623_bib47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/cmi.2015.06","article-title":"Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration, Cell","volume":"13","author":"Mathews","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0300-483X(99)00044-X","article-title":"Cytokines, growth factors, and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde, and LPS","volume":"134","author":"Guti\u00e9rrez-Ruiz","year":"1999","journal-title":"Toxicology"},{"key":"10.1016\/j.biomaterials.2025.123623_bib49","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.3390\/pharmaceutics14091894","article-title":"Nanoparticle delivery of novel PDE4B inhibitor for the treatment of alcoholic liver disease","volume":"14","author":"Ma","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123623_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cellsig.2018.06.005","article-title":"Role of cAMP and phosphodiesterase signaling in liver health and disease","volume":"49","author":"Wahlang","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biomaterials.2025.123623_bib51","doi-asserted-by":"crossref","first-page":"a16","DOI":"10.2741\/gouillon","article-title":"Role of CYP2E1 in the pathogenesis of alcoholic liver disease modifications by cAMP and Ubiquitin-proteasome pathway","volume":"4","author":"Gouillon","year":"1999","journal-title":"Front. Biosci."},{"key":"10.1016\/j.biomaterials.2025.123623_bib52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2025.123623_bib53","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.23837","article-title":"Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3","volume":"52","author":"Ki","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2025.123623_bib54","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biomaterials.2025.123623_bib55","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/biom12081035","article-title":"Advancements in the alcohol-associated liver disease model","volume":"12","author":"Zhu","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biomaterials.2025.123623_bib56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijpharm.2005.11.003","article-title":"Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice","volume":"308","author":"Saxena","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123623_bib57","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1016\/j.biomaterials.2014.04.019","article-title":"Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles","volume":"35","author":"Zhao","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123623_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101565","article-title":"Ethanol with thioacetamide murine model of alcoholic liver disease identifies hepatic pathways as targets for the human disease","volume":"30","author":"Mittal","year":"2025","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib59","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/hep.32612","article-title":"Macrophage\u2010derived MLKL in alcohol\u2010associated liver disease: regulation of phagocytosis","volume":"77","author":"Wu","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2025.123623_bib60","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2147\/IJN.S121881","article-title":"Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile","volume":"12","author":"Rafiei","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.biomaterials.2025.123623_bib61","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.apsb.2020.11.006","article-title":"S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling","volume":"11","author":"Luo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2025.123623_bib62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1751-2980.2010.00472.x","article-title":"Histopathological evaluation of fatty and alcoholic liver diseases: pathology of fatty liver disease","volume":"12","author":"Yerian","year":"2011","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.biomaterials.2025.123623_bib63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2025.123623_bib64","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","article-title":"Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role","volume":"35","author":"Aubert","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225005423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225005423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:58:26Z","timestamp":1779717506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225005423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":64,"alternative-id":["S0142961225005423"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123623","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel Kupffer cell-targeting nanoparticle system to Mitigate alcohol-associated liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"123623"}}